Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Celltrion announces USFDA approval of 300mg strength of OMLYCLO
    4 December 2025

    Celltrion announces USFDA approval of 300mg strength of OMLYCLO® (omalizumab-igec)

    Celltrion, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO® (omalizumab-igec), the first and only biosimilar designated as interchangeable with XOLAIR® (omalizumab), in a 300mg/2mL solution in a single-dose prefilled syringe for subcutaneous injection. In the U.S., OMLYCLO will be marketed and distributed exclusively by Celltrion USA, Inc.
  • 3 December 2025
    Sun Pharma introduces its global innovative drug, Ilumya® in India
    Sun Pharmaceutical Industries Ltd. announced the launch of its global innovative drug, ILUMYA (Tildrakizumab) in India for moderate-to-severe plaque psoriasis. A novel biologic treatment, ILUMYA has been endorsed widely by dermatologists in the US and worldwide for several years as an effective and safe treatment of moderate to severe plaque psoriasis.
  • 1 December 2025
    Sandoz launches denosumab biosimilars in Europe
    Sandoz the global leader in affordable medicines, today announced the European launch of Wyost® (denosumab 120 mg) and Jubbonti® (denosumab 60 mg).
  • 1 December 2025
    Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
    Novo Nordisk announced the submission of a sNDA to the U.S. Food and Drug Administration (FDA) for a higher dose of semaglutide injection 7.2 mg, to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity.
  • 27 November 2025
    Calcium-sensitive switch boosts the efficacy of cancer drugs
    Cancer-fighting antibody drugs are designed to penetrate tumor cells and release a lethal payload deep within, but too often they don’t make it that far. A new study shows how this Trojan Horse strategy works better by exploiting calcium differences outside and inside cells.
  • 27 November 2025
    Individuals with diabetes are more likely to suffer complications after stent surgery
    Patients with diabetes have an increased risk of complications after stent implantation, according to a study from Karolinska Institutet in Sweden published in Diabetes Care. The study, which includes over 160,000 patients, emphasises the importance of tailoring treatment strategies for this specific patient group.
  • 27 November 2025
    MHRA Approves SIILTIBCY® : A New and More Accurate Tuberculosis Skin Test for the UK

    In a major boost to global tuberculosis (TB) diagnostics, the Serum Institute of India Pvt. Ltd. (SIIPL), through its UK-based subsidiary Serum Life Sciences Ltd., announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted Marketing Authorisation for SIILTIBCY®, a next-generation skin test designed to detect infection caused by Mycobacterium tuberculosis.

    This authorization allows SIILTIBCY® to be used across the United Kingdom for adults and children, marking an important step toward more accurate and reliable TB detection.

  • 25 November 2025
    Scientists Discover “Two-Faced” Fat-Burning Enzyme That Controls Body’s Fat Storage From Inside the Nucleus
    In a breakthrough that reshapes our understanding of how the body manages fat, researchers have discovered that a well-known fat-burning enzyme, Hormone-Sensitive Lipase (HSL), has a second, unexpected job—acting inside the cell nucleus to regulate how fat cells grow, store energy, and function.
  • 25 November 2025
    Brain Enzyme OTULIN Emerges as a Surprising Master Switch in Tau Production - A New Frontier for Alzheimer’s Therapy
    Scientists have uncovered a previously unknown function of the enzyme OTULIN in regulating the production of tau, the protein that aggregates in neurodegenerative diseases such as Alzheimers.
  • 25 November 2025
    Breakthrough in Cancer Immunotherapy Using Marine Bacteria
    A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology (JAIST), has discovered that the marine bacterium Photobacterium angustum demonstrates remarkable therapeutic efficacy against colorectal cancer.
Subscribe to Pharma News